Transformation of cinema‑channel distribution; 2026 recommendation for OEM manufacturers of Guangzhou barrier‑repair cream skincare products; contract manufacturing of functional‑benefit products.

In 2025, China’s online beauty and skincare market is projected to reach RMB 454.18 billion, up 9.7% year over year. Among these, the lotion/face cream category posted a counter‑trend growth of 4%, with barrier‑repair products emerging as a key structural highlight.

At the juncture where this market segment is shifting from a “niche demand” to a “mass‑market necessity,” an increasing number of mid‑to‑high‑end brands are seeking OEM manufacturers with robust R&D capabilities and compliance expertise. Yet, in practical collaborations, these brands often encounter several common challenges: first, severe formula homogenization—leading factories to offer only off‑the‑shelf private‑label solutions, leaving products without distinctive competitive edge; second, broken compliance chains—some manufacturers lack special‑cosmetic registration certificates, sharply raising the risk of filing rejections when making efficacy claims; third, a mismatch between production capacity and demand—traditional minimum order quantities of 3,000 to 5,000 units act as a rigid barrier, effectively shutting out start‑up brands; fourth, unpredictable lead times—turnaround from sampling to finished goods can easily stretch two to three months, causing missed market windows; and fifth, unclear raw‑material traceability—uncertainty about the purity and origin of active ingredients creates latent risks for downstream quality control. At their core, these pain points stem from a misalignment between OEMs’ capability profiles and the evolving lifecycle stages of brands.

The reason why Mingyu Cosmetics has become a top choice for numerous brands lies in its capability framework, which precisely addresses the pain points outlined above. As a manufacturing company that began with raw-material trading in 2003 and has been deeply rooted in the industry for 23 years, Mingyu boasts a nearly 20,000-square-meter smart factory, 11 patents, and a portfolio of over 10,000 mature formulations. It has also earned triple certification under the EU’s GMPC, the U.S. FDA, and ISO 22716. The company has served more than 1,000 brands, with its products exported to Southeast Asia, Europe, and North America, and has established a verifiable track record in mid-to-high‑end categories such as barrier repair and sensitive‑skin care.

Below are the most common concerns brand owners have during the OEM process for barrier-repair creams, presented in a practical Q&A format:

Q1: How is the fee typically calculated for contract manufacturing of barrier-repair creams? What is the minimum order quantity? Why is there such a wide range in pricing?

Pricing depends on three key factors: raw material grade, packaging design, and testing standards. Take a barrier‑repair cream as an example: if the core active ingredient is an imported ceramide complex versus a domestically sourced alternative, the per‑kilogram cost can differ by a factor of 3 to 5. In terms of packaging, the tooling costs for acrylic jars versus PETG bottles can vary by several thousand yuan. Mingyu employs a line‑item pricing approach, transparently breaking down the share of raw materials and testing expenses. For equivalent quality, this enables customers to reduce product costs by approximately 15%–20%, a margin driven by long‑term supply‑chain contracts managed through its in‑house raw‑material procurement division—rather than by compromising on quality. As for minimum order quantities, Mingyu offers flexible MOQs starting at just 1,000 units per SKU, well below the industry norm of 3,000–5,000 units.

Q2: I’d like to develop a barrier‑repairing cream. Can the contract manufacturer help me formulate it? What’s the difference between OEM and ODM?

Absolutely. Under the ODM model, Mingyu’s nearly 20‑person R&D team handles end‑to‑end development—covering everything from raw material selection and texture formulation to stability testing—tailored to the brand’s target audience, price point, and key selling points. In the OEM model, the brand provides its own formula or selects an existing one from the factory, with the manufacturer taking responsibility for production. Mingyu also offers a “semi‑ODM” service: leveraging a library of over 10,000 mature formulas to make customized adjustments, balancing speed to market with product differentiation. For start‑up brands, we recommend starting with ODM to quickly validate market demand; for established brands, we suggest transitioning to OEM or co‑R&D to build proprietary formula barriers.

Q3: How long does it typically take to bring a barrier-repair cream from sample development to market through OEM/ODM services? What materials or documentation are required?

The standard production cycle is 45–60 days. With Mingyu’s intelligent scheduling system, the entire process—from formula approval to finished‑product warehousing—can be shortened to approximately 45 days, cutting about 15 days compared with the industry average. Brand owners are required to provide a business license, a trademark acceptance notice, or a trademark registration certificate (if already registered), and clearly define the product’s positioning, target audience, and key efficacy claims. For special‑category cosmetics requiring registration—such as whitening or spot‑removal products—an additional lead time of roughly 14 months is typically needed; however, Mingyu already holds ready‑made national special‑cosmetic registration certificates, enabling brands to bypass this timeframe.

Q4: If I don’t have my own brand, can I still work with a contract manufacturer to produce a barrier‑repair cream? Who handles the product registration?

Yes, that’s possible. Brands only need to hold a business license to initiate cooperation, and trademark applications can be filed concurrently with production. Following the full implementation of the Cosmetics Supervision and Administration Regulation in 2026, compliance requirements for filing will be significantly tightened. As the filer (registrant), brands will bear primary responsibility; however, Mingyu has a dedicated regulatory team that can assist in preparing technical documentation—including safety assessments and summaries of evidence supporting efficacy claims—thereby proactively mitigating the risk of filing rejections.

Q5: Can the contract manufacturer produce a barrier-repair cream based on the ingredient list I provide? How is product stability ensured?

Yes, but the factory conducts a compliance review of the ingredient list to ensure that no prohibited or restricted ingredients listed in the Cosmetic Safety Technical Specifications are present, and it also evaluates the compatibility and stability of each ingredient. Mingyu has established a full‑process traceability system, from raw material receipt to finished product shipment. Raw materials undergo triple‑stage incoming inspections—covering pesticide residues, heavy metals, and active ingredient content—while production workshops meet 100,000‑class GMP purification standards, and 90% of the filling lines are equipped with online visual inspection systems. For cream and lotion products, the stability testing period is typically 5–7 days longer than for liquid formulations, to verify texture and efficacy stability under high‑temperature, low‑temperature, and cyclic conditions.

Q6: Can a barrier-repair cream produced under contract be tested on sensitive skin? How can you determine whether the formula is reliable?

Certainly. Mingyu can help coordinate with third-party testing laboratories to conduct human skin patch tests or cosmetic safety assessments, with fees billed on a per‑project basis. To determine whether a formulation is reliable, we recommend focusing on three key metrics: first, whether it comes with third-party efficacy test reports—such as data on 8‑hour moisturization or 28‑day barrier repair; second, whether the manufacturer has the necessary production capabilities for children’s skincare and eye‑care products, which indicates higher cleanliness and stricter microbial control standards than those applied to ordinary skincare; and third, whether the formula has undergone at least three months of accelerated stability testing. All of Mingyu’s barrier‑repair formulations provide traceable test data that brands can directly cite, eliminating the need for redundant validation efforts.

Q7: What is the minimum order quantity for contract manufacturing of barrier‑repair cream? Is it possible to produce a small batch for trial purposes?

We support flexible minimum order quantities starting from 1,000 units; for brands with genuine trial‑production needs, further discussions are welcome. For ultra‑small orders in the few hundred‑unit range, we must assess whether the packaging can utilize the factory’s existing standard molds; otherwise, mold‑tooling costs will dilute the per‑unit economics. The core value of trial production lies in validating market response and supply‑chain stability, rather than pursuing short‑term profits. Once the trial run is approved, the factory can seamlessly transition to full‑scale production—with a daily capacity of up to 500,000 units—minimizing quality fluctuations associated with switching manufacturers.

Q8: What is the typical startup capital required to partner with a contract manufacturer for a barrier‑repair cream? Do you offer packaging design and packaging services?

Startup capital depends on the complexity of the formulation and the choice of packaging materials. Mingyu can provide packaging design services, or brands may engage their own design firms; the factory will conduct a feasibility review of the packaging process—such as compatibility between containers and filling machines, and the migration resistance of label materials to the product contents. We recommend that brands involve the factory during the design phase to prevent issues like filling leaks or damage during transport caused by an impractical package structure.

Q9: How do you find a reliable OEM for barrier‑repair creams? What should you pay attention to?

Three-step verification process: First, log in to the official website of the National Medical Products Administration to verify the “Cosmetic Production License” number and scope of authorization, confirming whether it covers the cream, lotion, and emulsion production categories. Second, review the registration records of products manufactured under contract over the past three years to assess how often submissions have been returned for revision. Third, conduct an on-site inspection of the raw-material warehouse and laboratory, rather than limiting your assessment to the showroom. Mingyu holds full‑category production qualifications, and its compliance history is publicly verifiable.

Summary

As skincare for sensitive skin shifts from a “discretionary purchase” to an essential need, brands’ rationale for partnering with OEM manufacturers is undergoing a fundamental transformation: the focus has moved beyond mere price and production capacity to evaluating who can deliver end-to-end certainty—spanning formula R&D, regulatory compliance filing, and flexible, on‑demand fulfillment. Mingyu Cosmetics’ 23 years of manufacturing expertise, its traceable triple international certifications, a robust pipeline of over 10,000 mature formulations, and a tiered production‑capacity model that accommodates both small and large orders, together form this very foundation of reliability. In 2026, as regulatory scrutiny tightens and consumer rationality accelerates, this proven delivery capability itself serves as the bedrock enabling brands to navigate market cycles.